AN ACT TO ESTABLISH THE MISSISSIPPI PARKINSON'S DISEASE RESEARCH REGISTRY WITHIN THE STATE DEPARTMENT OF HEALTH UNDER THE DIRECTION OF THE STATE HEALTH OFFICER; TO PROVIDE THAT THE STATE HEALTH OFFICER SHALL ESTABLISH AND APPOINT THE MEMBERS OF THE MISSISSIPPI PARKINSON'S DISEASE RESEARCH REGISTRY ADVISORY COMMITTEE TO ASSIST IN THE DEVELOPMENT AND IMPLEMENTATION OF THE REGISTRY, DETERMINE WHAT DATA WILL BE COLLECTED, AND ADVISE THE DEPARTMENT; TO DIRECT THE STATE BOARD OF HEALTH TO PROMULGATE RULES, IN CONSULTATION WITH THE ADVISORY COMMITTEE, TO DESIGNATE PARKINSON'S DISEASE AND IDENTIFIED PARKINSONISMS AS DISEASES THAT ARE REQUIRED TO BE REPORTED TO THE DEPARTMENT; TO REQUIRE THE DEPARTMENT TO RECEIVE AND COLLECT DATA FOR THE REGISTRY ON THE INCIDENCE AND PREVALENCE OF PARKINSON'S DISEASE AND PARKINSONISMS IN MISSISSIPPI AND RELATED EPIDEMIOLOGICAL DATA; TO REQUIRE, BEGINNING JANUARY 1, 2027, EACH MOVEMENT DISORDER CENTER THAT TREATS A PATIENT WITH PARKINSON'S DISEASE AND EACH MOVEMENT DISORDER HEALTH CARE PROVIDER WHO TREATS OR DIAGNOSES PARKINSON'S DISEASE OR PARKINSONISMS FOR A PATIENT TO SUBMIT A PARKINSON'S DISEASE REPORT TO THE DEPARTMENT; TO PROVIDE THAT A PATIENT WHO DOES NOT WISH TO PARTICIPATE IN THE COLLECTION OF DATA FOR THE PURPOSES OF RESEARCH IN THE REGISTRY MAY OPT OUT AFTER AN OPPORTUNITY TO REVIEW THE DOCUMENTS AND ASK QUESTIONS; TO AUTHORIZE THE DEPARTMENT TO MAKE DATA FROM THE REGISTRY, WITH OR WITHOUT IDENTIFIERS, AVAILABLE TO RESEARCHERS THAT HAVE THE APPROVAL OF AN INSTITUTIONAL REVIEW BOARD IN ACCORDANCE WITH REQUIREMENTS OF FEDERAL REGULATIONS; TO PROVIDE THAT ALL INFORMATION COLLECTED PURSUANT TO THIS ACT IS CONFIDENTIAL; TO REQUIRE THE DEPARTMENT TO MAINTAIN AN ACCURATE RECORD OF ALL PERSONS WHO ARE GIVEN ACCESS TO INFORMATION COLLECTED BY THE DEPARTMENT PURSUANT TO THIS ACT; TO REQUIRE THE DEPARTMENT TO PROVIDE NOTICE OF THE MANDATORY REPORTING REQUIRED UNDER THIS ACT ON ITS WEBSITE AND TO PROFESSIONAL ASSOCIATIONS REPRESENTING MOVEMENT DISORDER CENTERS AND MOVEMENT DISORDER HEALTH CARE PROVIDERS; TO REQUIRE THE DEPARTMENT TO SUBMIT TO THE CHAIRMEN OF THE HOUSE AND SENATE PUBLIC HEALTH COMMITTEES A YEARLY PROGRAM SUMMARY UPDATE; TO REQUIRE THE DEPARTMENT, BY OCTOBER 1, 2028, TO CREATE, AND UPDATE ANNUALLY THEREAFTER, THE MISSISSIPPI PARKINSON'S DISEASE RESEARCH REGISTRY WEBSITE WHERE THE PUBLIC CAN FIND INFORMATION RELATED TO PARKINSON'S DISEASE AND THE REGISTRY, THE YEARLY PROGRAM SUMMARY UPDATE, AND ANY OTHER INFORMATION DEEMED RELEVANT BY THE ADVISORY COMMITTEE; AND FOR RELATED PURPOSES.
The establishment of this registry is expected to have significant implications for state laws regarding health data collection and patient privacy. The bill stipulates mandatory reporting of cases of Parkinson's disease by healthcare providers, beginning January 1, 2027. Furthermore, patients will have the option to opt out of data collection if they do not wish to participate in research. This balance of mandatory data reporting with patient autonomy is a notable feature of the bill, aiming to enhance the quality of healthcare while respecting individual rights.
House Bill 999 aims to establish the Mississippi Parkinson's Disease Research Registry within the State Department of Health. This initiative is designed to improve the understanding, treatment, and epidemiological tracking of Parkinson's disease and related conditions in Mississippi. Specifically, the bill mandates that the State Health Officer oversee the creation and ongoing management of the registry, which will include the collection of data on the incidence and prevalence of Parkinson's disease as well as related conditions classified as Parkinsonisms. This registry will not only enhance data availability for state health monitoring but also facilitate research at various healthcare institutions across Mississippi.
Overall, the sentiment surrounding HB 999 appears to be largely supportive, particularly among lawmakers and healthcare professionals focused on public health advancements. Many stakeholders view this registry as a critical step towards better understanding Parkinson's disease within the state, which could eventually lead to improved patient outcomes. However, concerns have been raised about potential implications for patient privacy and the administrative burden placed on healthcare providers tasked with reporting under this law.
Notable points of contention include the implications of mandatory reporting on patient confidentiality and the potential for data misuse. While the bill ensures that all collected information will be kept confidential, there are questions regarding the effectiveness of these protections and the responsibilities of the State Department of Health in maintaining them. Additionally, the requirement for participation by healthcare providers may lead to resistance from some sectors, particularly if they perceive the requirements as burdensome or intrusive. The success of this bill will largely depend on how these concerns are addressed in the implementation phase.